Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Ramucirumab

EU orphan designation number: EU/3/12/1019
Active ingredient: Ramucirumab
Indication: Treatment of hepatocellular carcinoma
Sponsor: Eli Lilly Nederland B.V.
Papendorpseweg 83, 3528 BJ Utrecht, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Orphan designation EMA/OD/031/12 (2012)4773 of 04/07/2012
19/02/2016 Change of name and/or address of sponsor
22/02/2016 Removal of orphan designation from Community Register